Covered recipient · General Payments record
ASISAT A OPE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$4,855.13
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,074.30 | 6 |
| Consulting Fee | $1,000.00 | 1 |
| Food and Beverage | $639.75 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Moderna TX, Inc. | $2,680.30 | 16 |
| PFIZER INC. | $1,033.75 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ModernaTX, Inc. | $823.17 | 01/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152556167 | CMS |
| ModernaTX, Inc. | $191.30 | 01/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152556169 | CMS |
| ModernaTX, Inc. | $150.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556171 | CMS |
| ModernaTX, Inc. | $217.35 | 01/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152556173 | CMS |
| ModernaTX, Inc. | $50.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556175 | CMS |
| ModernaTX, Inc. | $25.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556177 | CMS |
| ModernaTX, Inc. | $50.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556179 | CMS |
| ModernaTX, Inc. | $25.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556181 | CMS |
| ModernaTX, Inc. | $336.95 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152556187 | CMS |
| ModernaTX, Inc. | $240.00 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152556189 | CMS |
| ModernaTX, Inc. | $265.53 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152556191 | CMS |
| ModernaTX, Inc. | $30.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556205 | CMS |
| ModernaTX, Inc. | $81.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556207 | CMS |
| ModernaTX, Inc. | $30.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556209 | CMS |
| ModernaTX, Inc. | $45.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556211 | CMS |
| ModernaTX, Inc. | $120.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152556213 | CMS |
| PFIZER INC. | $33.75 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131588047 | CMS |
| PFIZER INC. | $1,000.00 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1130891694 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.